In 2020, medicated cosmetics accounted for the largest amount of quasi-drugs production in Japan with close to 573 billion Japanese yen. Hair remedies accounted for the second largest production value with approximately 215.6 billion yen.
Production value of quasi-drugs in Japan in 2020, by therapeutic category (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Quasi drugs production value in Japan 2011-2020
- Breakdown of quasi-drugs production in Japan 2020, by therapeutic category
- Medicated cosmetics production value in Japan 2016, by items
- Medicated cosmetics production quantity in Japan 2016, by item
- Breakdown of quasi-drugs production in Japan 2016, by region
- Quasi-drugs production plants in Japan 2016, by region
- Hungary: pharmaceutical products imports value 2020
- Spain: pharmaceutical products imports value 2019
- Quasi-drug market size in South Korea 2012-2020
- Quasi-drug import value in South Korea 2012-2020
- Number of quasi-drugs approved by PMDA Japan FY 2012-2020
- Operating revenue of the sanitary and medical product market in China 2013-2019
- Manufacturing costs in pharmaceutical industry by country 2016
- Kimberly-Clark's global revenue of medical disposables 2013-2020
- U.S. pharmaceutical preparations ad spend 2018-2020
- U.S. pharmaceutical preparations: ad spend to sales ratio 2011-2015
- Sales volume of over the counter phytopharmaceuticals and homeopathy in Germany 2018
MHLW (Japan). (December 28, 2021). Production value of quasi-drugs in Japan in 2020, by therapeutic category (in billion Japanese yen) [Graph]. In Statista. Retrieved August 12, 2022, from https://www.statista.com/statistics/821009/japan-quasi-drug-production-value-by-therapeutic-category/
MHLW (Japan). "Production value of quasi-drugs in Japan in 2020, by therapeutic category (in billion Japanese yen)." Chart. December 28, 2021. Statista. Accessed August 12, 2022. https://www.statista.com/statistics/821009/japan-quasi-drug-production-value-by-therapeutic-category/
MHLW (Japan). (2021). Production value of quasi-drugs in Japan in 2020, by therapeutic category (in billion Japanese yen). Statista. Statista Inc.. Accessed: August 12, 2022. https://www.statista.com/statistics/821009/japan-quasi-drug-production-value-by-therapeutic-category/
MHLW (Japan). "Production Value of Quasi-drugs in Japan in 2020, by Therapeutic Category (in Billion Japanese Yen)." Statista, Statista Inc., 28 Dec 2021, https://www.statista.com/statistics/821009/japan-quasi-drug-production-value-by-therapeutic-category/
MHLW (Japan), Production value of quasi-drugs in Japan in 2020, by therapeutic category (in billion Japanese yen) Statista, https://www.statista.com/statistics/821009/japan-quasi-drug-production-value-by-therapeutic-category/ (last visited August 12, 2022)